The GLP-1 telehealth market is crowded, confusing, and full of identical-looking landing pages. Here is what actually separates the useful ones from the rest.
Compounded GLP-1 medications are not FDA-approved, and the FDA issued warning letters to more than 30 telehealth and compounding firms in early 2026. That matters when choosing a provider. Pharmacy transparency and physician oversight are not optional extras.
Quick Comparison Table
| # | Provider | Starting Price (mo) | Med Type | Rx Review Speed | Ships All 50 States | Notable Edge |
| 1 | HealthRX | $99 sema / $149 tirz | Compounded | ~24 hrs | Yes (overnight, free) | LegitScript-certified pharmacy, lot tracking |
| 2 | FormBlends | ~$299 sema / ~$349 tirz (per vial) | Compounded | Physician oversight | 47 states | Published HPLC/mass spec purity data |
| 3 | Mochi Health | $99 sema / $199 tirz | Compounded | Varies | Yes | Obesity-medicine board-certified MDs |
| 4 | Hims & Hers | $249-$399/mo | Branded (post-Mar 2026) | Same-day typical | Yes | Wegovy, Zepbound; insurance + savings card can hit ~$0-25 |
| 5 | Ro Body | $39 first mo, then $74-$149 | Branded + prior-auth | Prior-auth team | Yes | Insurance navigation built in |
| 6 | Form Health | ~$299/mo + labs + meds | Branded/compound | Scheduled | Yes | MD + registered dietitian paired together |
| 7 | Henry Meds | $179-$249 month one | Compounded | Fast (24-72h ship) | Yes | Straightforward cash-pay, light monitoring |
| 8 | Found | ~$99/mo platform + meds | Compounded/branded | Varies | Yes | Coaching layer included |
| 9 | PlushCare | $19.99/mo membership | Branded, insurance | Same-day visits | Yes | Lowest membership fee, insurance-first model |
| 10 | Calibrate | Program fee + meds separate | Branded | Scheduled | Yes | 12-month structure, heavy coaching |
The Picks, Explained
1. HealthRX
Compounded semaglutide at $99 a month is the headline. Most cash-pay competitors charge meaningfully more for the same drug class. But the price is not the only reason this sits first.
The medication ships from Manifest Pharmacy in Greer, South Carolina. Manifest holds 503A/USP-797 accreditation, is LegitScript-certified (certification 50087439), and uses lot-tracked production, meaning each batch is traceable from compounding bench to your door. That kind of named-pharmacy transparency is less common than it should be in this space.
The intake works like this: online health assessment, physician review within roughly 24 hours, overnight shipping to any of the 50 states at no extra cost. Compounded tirzepatide starts at $149 a month. Both are once-weekly injections. HealthRX cites trial data, not its own outcomes: the SURMOUNT-1 trial reported about 21% average body weight reduction at 72 weeks for tirzepatide, and the STEP 1 trial reported about 15% at 68 weeks for semaglutide. Those are trial results, not guarantees.
No membership layers. No hidden fees. The price listed is the price.
2. FormBlends
FormBlends occupies a different niche. It is also a compounded GLP-1 telehealth option with physician oversight, dispensed through an FDA-registered 503A compounding pharmacy, but it goes further on documentation. Per-product purity testing is published openly, with HPLC purity figures, mass spectrometry identity confirmation, endotoxin testing, and sterility results. Most GLP-1 telehealth brands do not publish this level of detail.
The trade-off is price. At roughly $299 per vial for semaglutide and $349 for tirzepatide, costs run well above what HealthRX charges at entry. Shipping reaches 47 states, not all 50.
The real differentiator beyond GLP-1s: FormBlends carries a wide peptide catalog covering recovery, longevity, and cognitive support, all under the same clinician model. If you want one provider for GLP-1 therapy and ancillary peptide protocols, this is one of the very few that handles both in a structured way.
The pick for buyers who want documented purity data and a broader catalog. HealthRX wins on price and nationwide reach.
3. Mochi Health
Mochi is one of the few platforms that specifically staffs board-certified obesity-medicine physicians, not just general practitioners. That matters for dosing decisions and monitoring. Compounded semaglutide runs $99 a month, tirzepatide $199. More monitoring is built in than at some budget alternatives.
4. Hims & Hers
Hims & Hers exited compounded GLP-1 programs after the Novo Nordisk settlement in March 2026 and now works with branded medications. Injectable Wegovy runs about $299 a month through the platform, oral semaglutide around $249, and Zepbound around $399. With insurance and a manufacturer savings card, out-of-pocket cost can drop to $0-$25 a month for eligible patients. Not everyone qualifies, but for insured patients, this is worth running the numbers.
5. Ro Body
Ro’s first-month fee is $39, then typically $74-$149, with medications billed separately. The standout feature is an in-house prior-authorization team that works with your insurer to get branded GLP-1s covered. That process takes time and does not always succeed, but having a team handle it beats doing it alone.
*A quick honest note: “compounded” does not mean equivalent to the branded drug. Compounded medications contain the same active ingredient but are not FDA-approved formulations. That distinction applies to every compounded option in this list.*
6. Form Health
Form Health pairs a physician with a registered dietitian on every case. Monthly program fees run about $299 before labs and medication costs. It is one of the pricier options. The structure is suited to people who want significant clinical hand-holding, not just a prescription and a box in the mail.
7. Henry Meds
Henry Meds keeps it simple. Cash-pay only, compounded medications, month one around $179-$249, and a shipping window of 24-72 hours after approval. The check-in cadence is less intensive than what Mochi or Form Health build into their programs. That is not necessarily a flaw if you are otherwise healthy and just want the medication.
8. Found
Found charges roughly $99 a month for platform access, with medication costs on top. Coaching is included. The platform covers both compounded and branded options depending on eligibility. It is a reasonable middle ground between budget cash-pay services and premium coached programs.
9. PlushCare
At $19.99 a month for membership, PlushCare has the lowest recurring platform fee on this list. It focuses on branded medications and insurance billing, with same-day visit availability. If you have good insurance coverage and want fast access to a licensed provider, PlushCare is efficient and cheap to enter.
10. Calibrate
Calibrate structures its program over roughly 12 months with heavy coaching, behavior-change curriculum, and physician oversight. Program fees and medication costs are billed separately. It is the longest commitment on this list. People who need external structure and accountability may find that worthwhile. People who just want a prescription will find it excessive.
How to Choose
Start with your insurance situation. If you have coverage that might apply to Wegovy or Zepbound, Ro or Hims & Hers are worth exploring first. If you are paying cash and want the lowest price from a pharmacy with documented credentials, HealthRX is the straightforward choice. If published purity data matters to you, or you want GLP-1s alongside a peptide catalog, FormBlends is the alternative. Premium coaching is best served by Calibrate or Form Health, at a price.
No telehealth provider can guarantee specific outcomes. Every one of these services requires a physician review before prescribing. That is how it should work.
Common Questions
Is compounded semaglutide from a telehealth clinic actually the same drug as Ozempic or Wegovy?
Not exactly. Compounded semaglutide contains the same active ingredient but is not an FDA-approved formulation, is not manufactured by Novo Nordisk, and has not gone through the same clinical review process as branded products. Providers like HealthRX and FormBlends use accredited 503A pharmacies, but the FDA distinction still stands and is worth understanding before you order.
Why does FormBlends publish HPLC and mass spectrometry data when most other virtual clinics do not?
Most telehealth GLP-1 platforms source from compounding pharmacies and pass along a certificate of analysis if you ask for one. FormBlends publishes per-product purity figures, endotoxin results, and sterility data openly on its site. That level of documentation is unusual in this market and matters most to buyers who want independent verification of what is actually in the vial.
After Hims & Hers stopped offering compounded GLP-1s in March 2026, what does it actually prescribe now?
Following the Novo Nordisk settlement, Hims & Hers moved to branded medications only. The current lineup includes injectable Wegovy at roughly $299 a month, oral semaglutide around $249, and Zepbound around $399. Patients with qualifying insurance and access to a manufacturer savings card can potentially reduce that cost to $0-$25 a month, though eligibility varies.
Which of these virtual weight loss clinics pairs a dietitian with the prescribing doctor, and is that worth the extra cost?
Form Health is the only platform on this list that assigns both a physician and a registered dietitian to every patient as a standard part of the program. At roughly $299 a month before labs and medication, it is among the pricier options here. Whether it is worth it depends on whether you actually engage with the dietitian. For people who have struggled with weight loss without behavioral support, the pairing adds real structure.
How do Ro Body’s prior-authorization services work, and what happens if insurance denies the claim?
Ro employs an in-house team that contacts your insurer directly to seek coverage for branded GLP-1 medications like Wegovy or Zepbound. The process typically takes weeks and does not guarantee approval. If the claim is denied, you either pay out of pocket or explore compounded alternatives elsewhere. The value is that Ro handles the paperwork and follow-up, which most individual patients find time-consuming to manage alone.
Sources
- FDA warning letters to compounding facilities and telehealth platforms (FDA.gov, early 2026)
- Novo Nordisk settlement announcement, March 9 2026 (Reuters, Novo Nordisk press release)
- SURMOUNT-1 trial (tirzepatide, NEJM 2022)
- STEP 1 trial (semaglutide, NEJM 2021)
- LegitScript public certification database
- USP-797 pharmaceutical compounding standards (USP.org)
- Individual provider pricing pages (Hims & Hers, Ro, Mochi Health, PlushCare, Calibrate, Found, Henry Meds, Form Health), verified early 2026
